PHC Corporation and CCRM have signed a Master Collaboration Agreement to collaborate on developing primary T-cell expansion ...

According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

Precision manufacturer Machine Sciences partners with Fastems to automate six work cells.

Trenchant partnered with Autolomous, integrating its digital solution into its CGT manufacturing platform, for faster production and lower costs.

PHC has partnered with CCRM to boost cell quality with advanced T-cell expansion solutions. Takeaway Points  PHC has ...

In 2023, the market was valued at USD 600.2 million, showcasing robust performance that translates into a year-over-year (Y-o-Y) growth of 4.0% for 2024. This trajectory underlines the sector’s ...

PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary ...